ClinVar Miner

Submissions for variant NM_015100.4(POGZ):c.118A>G (p.Thr40Ala)

dbSNP: rs2102370481
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Molecular Genetics, Royal Melbourne Hospital RCV002221409 SCV002498669 uncertain significance Intellectual disability-microcephaly-strabismus-behavioral abnormalities syndrome 2021-10-01 criteria provided, single submitter clinical testing This sequence change in POGZ is predicted to replace threonine with alanine at codon 40 (p.(Thr40Ala)). The threonine residue is moderately conserved (100 vertebrates, UCSC), and is located in a region of moderate missense constraint in no annotated domain (DECIPHER). There is a small physicochemical difference between threonine and alanine. This variant is absent from gnomAD v2.1 and v3.1. To our knowledge, this variant has not been reported in the literature in any individuals with a neurodevelopmental condition. Multiple lines of computational evidence predict a benign effect for the missense substitution (6/6 algorithms). Based on the classification scheme RMH Modified ACMG Guidelines v1.4.0, this variant is classified as a VARIANT OF UNCERTAIN SIGNIFICANCE. Following criteria are met: PM2_Supporting, BP4.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.